Eton Pharmaceuticals, Inc. (ETON) Shareholders’ equity 2019–2025
Eton Pharmaceuticals, Inc. (ETON) shareholders’ equity at each fiscal year-end, per SEC filings.
$26.2MFY2025 · since FY2019: $10.6M → $26.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $26.2M | +7.1% |
| FY2024 | $24.4M | +57.8% |
| FY2023 | $15.5M | +18.3% |
| FY2022 | $13.1M | -25.8% |
| FY2021 | $17.6M | +0.0% |
| FY2020 | $17.6M | +67.1% |
| FY2019 | $10.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice